Want to join the conversation?
Biopharma company $AMGN and Japanese pharma company Daiichi Sankyo said they have signed an agreement to commercialize 9 biosimilars in Japan, including some biosimilars in late-stage development like biosimilars of adalimumab, bevacizumab and trastuzumab. Financial terms of the deal were not disclosed.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?